Phase 1 Asian PK Study of ABBV-CLS-7262, an Eif2b Activator Being Developed As a Potential Treatment for Amyotrophic Lateral Sclerosis and Vanishing White Matter Disease (P5-11.014)
Neurology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined